MedTrace Logo

Medical Chitosan or Sodium Hyaluronate for Knee Osteoarthritis (CHOOSE)

NCT02323451 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 270

Last updated 2014-12-24

No results posted yet for this study

Summary

This study evaluates the safety and efficacy of investigational products in the treatment of knee Osteoarthritis. Half of participants will receive medical chitosan, while the other half will receive sodium hyaluronate.

Conditions

  • Osteoarthritis, Knee

Interventions

DEVICE

Medical Chitosan

intra-articular injection

DRUG

Sodium Hyaluronate Injection

intra-articular injection

Sponsors & Collaborators

  • Shanghai Qisheng Biological Preparation Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Changqing Zhang, PhD · Shanghai,China.Shanghai Sixth People's Hospital. Orthopedics. Recruiting. No. 600. Yishan Rd. Shanghai. Post Code:200233.

  • Shigui Yan, PhD · Hangzhou,Chian. The Second Affiliated Hospital of Zhejiang University School of Medicine. Orthopedics. Not yet recruiting. No.88 Jiefang Road Hangzhou.China Post Code：310009

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2016-08-31
Completion
2017-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02323451 on ClinicalTrials.gov